Latest filing published 29 Jul 2026 for Beam Therapeutics Inc., €376k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Amy Simon in Beam Therapeutics Inc. The record holds 21 filings, for trades running from 31 March 2023 to 27 July 2026.
No open-market purchase appears, only 16 sales worth €2.3M. Other entries cover 5 share grants. Since January 2026: no purchases and 3 sales on the market.
The newest entry dates from 29 July 2026: an open-market sale of €376k, in Beam Therapeutics Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations